Rockwell Medical, Inc (RMTI)

Etorro trading 970x250
Rockwell Medical, Inc (RMTI) Logo

About Rockwell Medical, Inc

Rockwell Medical, Inc. operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis. It is also developing an intravenous formulation of Triferic for use by hemodialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient’s bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. Its target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1994 and is based in Wixom, Michigan. Address: 411 Hackensack Avenue, Hackensack, NJ, United States, 07601

Rockwell Medical, Inc News and around…

Latest news about Rockwell Medical, Inc (RMTI) common stock and company :

Rockwell Medical, Inc. to Present at H.C. Wainwright Annual Global Life Sciences Conference
23 May, 2022 Yahoo! Finance

Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that Russell Ellison, M.D., M.Sc., President and Chief Executive Officer is scheduled to present at H.C. Wainwright's Annual Global Life Sciences Conference in Miami, Florida on Tuesday, May 24th at 3:30 PM ET.

76 Biggest Movers From Yesterday
19 May, 2022 FinancialContent

Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on ...

41 Stocks Moving In Wednesday's Mid-Day Session
18 May, 2022 FinancialContent

Gainers Decisionpoint Systems, Inc. (NYSE: DPSI) shares jumped 83.2% to $8.74. DecisionPoint Systems recently reported ...

20 Stocks Moving in Wednesday's Pre-Market Session
18 May, 2022 FinancialContent

Gainers Decisionpoint Systems, Inc. (NASDAQ: DPSI) rose 47.2% to $7.02 in pre-market trading after jumping around 19% on Tuesday. ...

Recap: Rockwell Medical Q1 Earnings
16 May, 2022 FinancialContent

Rockwell Medical (NASDAQ:RMTI) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know ...

Rockwell Medical Provides First Quarter 2022 Financial and Operational Update
16 May, 2022 Yahoo! Finance

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today reported financial results and a business update for the three months ended March 31, 2022.

Earnings Scheduled For May 16, 2022
16 May, 2022 FinancialContent

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at ...

Preview: Rockwell Medical's Earnings
13 May, 2022 FinancialContent

Rockwell Medical (NASDAQ:RMTI) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
13 May, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! We're starting off the final day of the workweek with an overview of the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

90 Biggest Movers From Yesterday
13 May, 2022 FinancialContent

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. ...

12 Health Care Stocks Moving In Thursday's Intraday Session
12 May, 2022 FinancialContent

Gainers Allena Pharma (NASDAQ:ALNA) shares moved upwards by 103.7% to $0.16 during Thursday's regular session. As of ...

Rockwell Medical Submits Additional Data For IND Application For Iron Deficiency Candidate
12 May, 2022 FinancialContent

Rockwell Medical Inc(NASDAQ: RMTI) hasprovided the FDA with the supplemental datarequested by the agency in ...

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
12 May, 2022 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BridgeBio Inks Licensing ...

Rockwell Medical Submits Supplemental Data to FDA for IND Application for Phase 2 FPC Home Infusion Trial
12 May, 2022 Yahoo! Finance

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that it provided the U.S. Food and Drug Administration (FDA) with the supplemental data, requested by the agency in December 2021, for the Company's pending Investigational New Drug (IND) application in support of a proposed Phase 2 clinical trial of Ferric Pyrophosphate Citrate (FPC) for the treatment of iron deficiency anemia and m

12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 May, 2022 FinancialContent

Gainers Allena Pharma (NASDAQ:ALNA) stock increased by 94.9% to $0.15 during Thursday's pre-market session. The ...

Rockwell Medical Announces 1-for-11 Reverse Stock Split
12 May, 2022 Yahoo! Finance

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that its Board of Directors has approved a 1-for-11 reverse split of the Company's issued and outstanding common stock (the "Reverse Stock Split"). The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on May 13, 2022. Rockwell Medical's common stock is expected to begin trading on the Nasdaq Capital Market on a sp

Rockwell Medical, Inc. to Report First Quarter 2022 Financial and Operating Results on May 16, 2022
11 May, 2022 Yahoo! Finance

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it will host a conference call on Monday, May 16 at 4:15 PM ET to discuss its financial results for the three months ended March 31, 2022, and recent operational highlights.

Perrigo (PRGO) Q1 Earnings Lag Estimates
11 May, 2022 Yahoo! Finance

Perrigo (PRGO) delivered earnings and revenue surprises of -21.43% and 1.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Lantheus Holdings (LNTH) Beats Q1 Earnings and Revenue Estimates
29 Apr, 2022 Yahoo! Finance

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 110.87% and 26.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical Announces Completion of Patient Enrollment Ahead of Schedule in Pivotal Phase 3 Clinical Trial of Triferic® in China
25 Apr, 2022 Yahoo! Finance

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that its partner, Wanbang Biopharmaceuticals enrolled the final patient, ahead of schedule, in its pivotal Phase 3 clinical trial for Triferic® (ferric pyrophosphate citrate) Dialysate to support a new drug application for regulatory approval in China. Wanbang Biopharmaceuticals is a subsidiary of Shanghai Fosun Pharmaceutical (Group

Rockwell Medical to Present at Noblecon18 Investor Conference
20 Apr, 2022 Yahoo! Finance

Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients, today announced that the company is scheduled to present at the Noblecon18, Noble Capital Market's 18th Annual Investor Conference in Hollywood, Florida, on Thursday, April 21st at 10:00 AM ET.

12 Health Care Stocks Moving In Monday's After-Market Session
18 Apr, 2022 FinancialContent

Gainers Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands ...

Rockwell Medical's Return On Capital Employed Insights
11 Apr, 2022 FinancialContent

Benzinga Pro data, Rockwell Medical (NASDAQ:RMTI) reported Q4 sales of $15.33 million. Earnings fell to a loss of $8.94 million, ...

Rockwell Medical Expands Partnership with DaVita
11 Apr, 2022 Yahoo! Finance

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced an expanded partnership with DaVita Inc. (NYSE: DVA), a leading kidney care provider. Rockwell Medical has been working to revise certain terms of its supply contracts with customers in an effort to stabilize its concentrates business. These two agreements with DaVita are designed to help ensure that Rockwell Medical is on a more sta

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
28 Mar, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! It's time to start off the week with an overview of the biggest pre-market stock movers for Monday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Get in Now on Tiny $3 ‘Forever Battery’ Stock It doesn’t matter if you have $500 in savings or $5 million. Do this now. Stock Prodigy Who Found NIO at $2… Says Buy THIS Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

64 Biggest Movers From Friday
28 Mar, 2022 FinancialContent

Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported ...

12 Health Care Stocks Moving In Friday's Intraday Session
25 Mar, 2022 FinancialContent

Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 25.0% to $2.15 during Friday's regular session. HOOKIPA ...

New Survey from Rockwell Medical Reveals Management of Iron Deficiency Anemia in Home Infusion Patients Does Not Adequately Address Medical Need
15 Mar, 2022 Yahoo! Finance

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today presented survey findings in oral and poster presentations at the National Home Infusion Association's (NHIA) 2022 Annual Conference, taking place March 12 through 16, 2022 in Nashville, Tennessee.

Rockwell Medical Announces Upcoming Poster Presentation at the National Home Infusion Association’s 2022 Annual Conference
09 Mar, 2022 Yahoo! Finance

WIXOM, Mich., March 09, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced a poster presentation at the National Home Infusion Association’s (NHIA) 2022 Annual Conference, to be held March 12-16 in Nashville, Tennessee. Details of the poster presentation are as follows:

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
08 Mar, 2022 FinancialContent

Gainers Stealth BioTherapeutics (NASDAQ:MITO) shares increased by 22.1% to $0.65 during Tuesday's pre-market ...

Rockwell Medical, Inc (RMTI) is a NASDAQ Common Stock listed in , ,

970x250